Dagmar Kubitza - Researcher Profile | RDL Research Database

Publications

2 shown

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects

Dagmar Kubitza , Michael Becka , Georg Wensing +2 more

2005 European Journal of Clinical Pharmaco... 648 citations

Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

Dagmar Kubitza , Michael Becka , Angelika Roth +1 more

Each single dose of rivaroxaban was well tolerated, with predictable pharmacokinetics and pharmacodynamics at doses up to 40 mg, and provided effective anticoagulation in health...

2008 Current Medical Research and Opinion 270 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 918
Institution: Bayer (Germany)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8450-473X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.